Broad Range of Partnered and Proprietary Products



PRODUCT, COLLABORATION PRODUCTS
AND PRODUCT CANDIDATES
THERAPEUTIC
AREA
RESEARCH FOCUS
(PARTNER)
  • Preclinical
  • Phase 1
  • Phase 2
  • Phase 3
  • Filed
  • Approved

ONCOLOGY PIPELINE & PRODUCT CANDIDATES

 
 
 
 
 
 
PEGPH20 with ABRAXANE® (nab-paclitaxel)
and gemcitabine
Oncology
Pancreas Cancer
 
 
 
 
 
 
PEGPH20 with TECENTRIQ® (atezolizumab)
Oncology
Pancreas Cancer (Genentech)
 
 
 
 
 
 
PEGPH20 with TECENTRIQ® (atezolizumab)
Oncology
Gastric Cancer (Genentech)
 
 
 
 
 
 
PEGPH20 with TECENTRIQ® (atezolizumab)
Oncology
Gall Bladder Cancer & Cholangiocarcinoma
 
 
 
 
 
 
PEG-ADA2: PEGylated-Human Adenosine
Deaminase 2
 
 
 
 
 
 
 
 

*No further clinical development planned on the Phase 2 portion of this study.

Notice

You are now leaving Halozyme.com. Halozyme is not responsible for or endorses the content of the linked site.

Ok